Showing results (1231-1240 of 1,294) with videos related to
Sort By:
Pageof 130
Paediatric Drugs|April 2, 2022
Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic ArthritisSiobhan M Case, Peter A NigrovicPaediatric Drugs|October 15, 2019
Applying Pharmacodynamics and Antimicrobial Stewardship to Pediatric Preseptal and Orbital CellulitisGrant T Stimes, Jennifer E GirottoPaediatric Drugs|July 2, 2019
Botulinum Toxin in the Management of Children with Cerebral PalsyIqbal Multani, Jamil Manji, Tandy Hastings-Ison, et al.Paediatric Drugs|August 11, 2020
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity DisorderAkwete L Adjei, Inder Chaudhary, Scott H Kollins, et al.Paediatric Drugs|April 8, 2021
Impact of the Implementation of a Vancomycin Protocol on Trough Serum Vancomycin Concentrations in a Pediatric Intensive Care UnitRaíssa Queiroz Rezende, Cícero Armídio Gomes Dias, Claudia Pires Ricachinevsky, et al.Paediatric Drugs|May 4, 2023
Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative ReviewHadi Sahrai, Mahdi Hemmati-Ghavshough, Marzieh Shahrabi, et al.Paediatric Drugs|June 19, 2012
Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infantsGian Maria PacificiPaediatric Drugs|July 7, 2012
Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort studyMatthew O Wiens, Stuart MacLeod, Victor Musiime, et al.Paediatric Drugs|March 28, 2015
Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective ReviewDaniel Rainkie, Mary H H Ensom, Roxane CarrPaediatric Drugs|June 6, 2014
Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilanceKevin V Blake, Cosimo Zaccaria, Francois Domergue, et al.Pageof 130